Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | FGFR2 |
Variant | K310R |
Impact List | missense |
Protein Effect | gain of function - predicted |
Gene Variant Descriptions | FGFR2 K310R lies within Ig-like C2-type domain 3 of the Fgfr2 protein (UniProt.org). K310R results in proliferation similar to wild-type Fgfr2 in a competition assay but increased transformation activity in cultured cells (PMID: 34272467), and therefore, is predicted to lead to a gain of Fgfr2 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
FGFR2 mutant FGFR2 act mut FGFR2 K310R FGFR2 mutant FGFR2 exon7 FGFR2 K310R |
Transcript | NM_000141.5 |
gDNA | chr10:g.121519989T>C |
cDNA | c.929A>G |
Protein | p.K310R |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_024447891.1 | chr10:g.121515190T>C | c.929A>G | p.K310R | RefSeq | GRCh38/hg38 |
NM_001144917.2 | chr10:g.121519989T>C | c.929A>G | p.K310R | RefSeq | GRCh38/hg38 |
NM_001144917.1 | chr10:g.121519989T>C | c.929A>G | p.K310R | RefSeq | GRCh38/hg38 |
NM_001320658 | chr10:g.121519989T>C | c.929A>G | p.K310R | RefSeq | GRCh38/hg38 |
XM_006717712 | chr10:g.121515190T>C | c.929A>G | p.K310R | RefSeq | GRCh38/hg38 |
XM_017015925.3 | chr10:g.121515187T>C | c.929A>G | p.K310R | RefSeq | GRCh38/hg38 |
NM_022970 | chr10:g.121519989T>C | c.929A>G | p.K310R | RefSeq | GRCh38/hg38 |
NM_001144913 | chr10:g.121519989T>C | c.929A>G | p.K310R | RefSeq | GRCh38/hg38 |
NM_022970.4 | chr10:g.121519989T>C | c.929A>G | p.K310R | RefSeq | GRCh38/hg38 |
XM_017015924 | chr10:g.121515187T>C | c.929A>G | p.K310R | RefSeq | GRCh38/hg38 |
NM_022970.3 | chr10:g.121519989T>C | c.929A>G | p.K310R | RefSeq | GRCh38/hg38 |
NM_001144917 | chr10:g.121519989T>C | c.929A>G | p.K310R | RefSeq | GRCh38/hg38 |
NM_000141.5 | chr10:g.121519989T>C | c.929A>G | p.K310R | RefSeq | GRCh38/hg38 |
NM_001144913.1 | chr10:g.121519989T>C | c.929A>G | p.K310R | RefSeq | GRCh38/hg38 |
XM_024447891.2 | chr10:g.121515190T>C | c.929A>G | p.K310R | RefSeq | GRCh38/hg38 |
XM_017015925 | chr10:g.121515187T>C | c.929A>G | p.K310R | RefSeq | GRCh38/hg38 |
NM_001320658.1 | chr10:g.121519989T>C | c.929A>G | p.K310R | RefSeq | GRCh38/hg38 |
XM_017015925.2 | chr10:g.121515187T>C | c.929A>G | p.K310R | RefSeq | GRCh38/hg38 |
NM_001144913.1 | chr10:g.121519989T>C | c.929A>G | p.K310R | RefSeq | GRCh38/hg38 |
NM_000141.4 | chr10:g.121519989T>C | c.929A>G | p.K310R | RefSeq | GRCh38/hg38 |
NM_001320658.2 | chr10:g.121519989T>C | c.929A>G | p.K310R | RefSeq | GRCh38/hg38 |
XM_017015924.2 | chr10:g.121515187T>C | c.929A>G | p.K310R | RefSeq | GRCh38/hg38 |
XM_017015924.3 | chr10:g.121515187T>C | c.929A>G | p.K310R | RefSeq | GRCh38/hg38 |
NM_000141 | chr10:g.121519989T>C | c.929A>G | p.K310R | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|